Feb 5, 2025 · Treatment goals are to ease pain and inflammation, improve strength and flexibility, and prevent joint damage. Treatment usually includes medicines to ease inflammation and …

1.5 Enthesitis-Related Arthritis COSENTYX is indicated for the treatment of active enthesitis-related arthritis (ERA) in pediatric patients 4 years of age and older.

ERA Enthesitis-related arthritis (ERA) is a type of JIA that affects the tissue where the muscles, ligaments, or tendons meet the bone (entheses). Symptoms may include swelling, joint pain, …

Cosentyx is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional …

Jan 29, 2025 · Overview: Cosentyx is used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. Common side effects include infection in the nose …

Sep 23, 2025 · Cosentyx for enthesitis-related arthritis Enthesitis is inflammation that affects the entheses, which are areas on the bones where the tendons and ligaments attach.

Feb 2, 2022 · The FDA has approved the use of secukinumab for pediatric patients with enthesitis-related arthritis and psoriatic arthritis, after research showed a longer time to …

Nov 6, 2025 · Cosentyx (secukinumab) is a biologic medication used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, enthesitis-related arthritis, hidradenitis suppurativa …

Oct 21, 2025 · Enthesitis-related arthritis (ERA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active enthesitis-related arthritis in …

Enthesitis-Related Arthritis (ERA) and Juvenile Psoriatic Arthritis (JPsA) Juvenile idiopathic arthritis is the most common form of arthritis in kids and teens and includes 7 types. …